Cargando…
Increased gene delivery efficiency and specificity of a lipid-based nanosystem incorporating a glycolipid
Hepatocellular carcinoma (HCC) is the third most common cause of death related to cancer diseases worldwide. The current treatment options have many limitations and reduced success rates. In this regard, advances in gene therapy have shown promising results in novel therapeutic strategies. However,...
Autores principales: | Magalhães, Mariana, Farinha, Dina, Pedroso de Lima, Maria Conceição, Faneca, Henrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216029/ https://www.ncbi.nlm.nih.gov/pubmed/25368518 http://dx.doi.org/10.2147/IJN.S69822 |
Ejemplares similares
-
A Combined Antitumor Strategy Mediated by a New Targeted Nanosystem to Hepatocellular Carcinoma
por: Farinha, Dina, et al.
Publicado: (2021) -
Non-Viral Gene Delivery Systems
por: Faneca, Henrique
Publicado: (2021) -
Editorial on Special Issue “Lipid Nanosystems for Local Drug Delivery”
por: Catita, José, et al.
Publicado: (2023) -
MicroRNA modulation combined with sunitinib as a novel therapeutic strategy for pancreatic cancer
por: Passadouro, Marta, et al.
Publicado: (2014) -
Development of a Novel Lipid-Based Nanosystem Functionalized with WGA for Enhanced Intracellular Drug Delivery
por: Hädrich, Gabriela, et al.
Publicado: (2022)